ImmunityBio Inc. Common Stock vs nVent Electric — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while nVent Electric trades at $166.3 (market cap $27.16B). The key difference: nVent Electric is far larger — about 2.6× ImmunityBio Inc. Common Stock's market cap, and nVent Electric pays a 0.5% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and nVent Electric for 11 Days on average.
| IBRX | NVT | |
|---|---|---|
Market Cap | $10.33B | $27.16B |
Volume | 11,745,198 | 1,530,782 |
Sector | Health | Industrials |
52-Week High | $11.55 | $184.34 |
52-Week Low | $1.98 | $94.99 |
Typical Hold Time | 0 Days | 11 Days |
Enterprise Value | $10.79B | $28.54B |
Dividend Yield | — | 0.5% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →nVent provides electrical connection and protection solutions, including enclosures, fastening systems, and thermal management products. Its products help support electrical and industrial infrastructure across multiple end markets.
Read more on NVT →